|
Market Closed -
Toronto S.E.
13:08:50 2026-10-15 EDT
|
5-day change | 1st Jan Change | ||
| 4.110 CAD | -3.75% |
|
+37.92% | +260.53% |
| 09-28 | Medicure Inc. Completes Enrollment In Its MEND-PNPO Phase 3 Clinical Trial | CI |
| 09-09 | Medicure Presents Mend-Pnpo Phase 3 Study Design and Baseline Data At the 16Th European Epilepsy Congress | CI |
Company Valuation: Medicure Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 12.44 | 9.431 | 10.35 | 14.61 | 9.184 | 11.9 |
| Change | - | -24.17% | 9.78% | 41.12% | -37.14% | 29.55% |
| Enterprise Value (EV) 1 | 11.17 | 6.906 | 6.346 | 8.786 | 2.867 | 8.953 |
| Change | - | -38.16% | -8.11% | 38.45% | -67.37% | 212.3% |
| P/E | -1.86x | -13x | 7.71x | -15.6x | -8.8x | -1.68x |
| PBR | 0.64x | 0.51x | 0.49x | 0.73x | 0.44x | 0.92x |
| PEG | - | 0.1x | -0x | 0x | -0.8x | -0x |
| Capitalization / Revenue | 1.07x | 0.43x | 0.45x | 0.67x | 0.42x | 0.41x |
| EV / Revenue | 0.96x | 0.32x | 0.28x | 0.4x | 0.13x | 0.31x |
| EV / EBITDA | -2.18x | 19.1x | 2.21x | 9.42x | -2.83x | -1.77x |
| EV / EBIT | -1.45x | -2.77x | 5.32x | -10.3x | -1.05x | -1.3x |
| EV / FCF | 2.66x | 6.01x | 4.87x | 3.73x | 5x | 4.07x |
| FCF Yield | 37.6% | 16.6% | 20.5% | 26.8% | 20% | 24.6% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.6406 | -0.0709 | 0.131 | -0.09 | -0.1 | -0.68 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 11.61 | 21.74 | 23.06 | 21.69 | 21.91 | 28.86 |
| EBITDA 1 | -5.132 | 0.361 | 2.873 | 0.933 | -1.014 | -5.06 |
| EBIT 1 | -7.686 | -2.495 | 1.193 | -0.854 | -2.737 | -6.888 |
| Net income 1 | -6.845 | -0.727 | 1.365 | -0.922 | -1.039 | -7.097 |
| Net Debt 1 | -1.269 | -2.525 | -4.008 | -5.825 | -6.317 | -2.944 |
| Reference price 2 | 1.190 | 0.920 | 1.010 | 1.400 | 0.880 | 1.140 |
| Nbr of stocks (in thousands) | 10,451 | 10,251 | 10,251 | 10,436 | 10,436 | 10,436 |
| Announcement Date | 4/20/21 | 4/27/22 | 4/6/23 | 4/8/24 | 4/25/25 | 4/23/26 |
1CAD in Million2CAD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 30.21M | |
| 20.07x | 7.14x | 14.31x | 1.48% | 68.98B | |
| 28.61x | 7.85x | 24.63x | 0.05% | 53.15B | |
| 35.29x | 6.26x | 18.73x | 0.92% | 50.83B | |
| 34.21x | 3.36x | 14.49x | -.--% | 44.61B | |
| -19.62x | 197.94x | -20.83x | -.--% | 40.57B | |
| 49.56x | 5.68x | 31.19x | -.--% | 42.53B | |
| 27.19x | 7.72x | 19.99x | 0.39% | 30.95B | |
| 29.37x | 6.23x | 16.17x | -.--% | 25.44B | |
| -13.66x | 5.14x | -6.23x | -.--% | 22.66B | |
| Average | 21.22x | 27.48x | 12.49x | 0.32% | 37.98B | |
| Weighted average by Cap. | 23.22x | 26.76x | 13.87x | 0.43% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- MPH Stock
- Valuation Medicure Inc.
Select your edition
All financial news and data tailored to specific country editions
